Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project
- 31 March 2011
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 47 (4), 561-571
- https://doi.org/10.1016/j.ejca.2010.10.022
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- Chromosome 1p and 11q Deletions and Outcome in NeuroblastomaThe New England Journal of Medicine, 2005
- Surgical Risk Factors in Primary Surgery for Localized Neuroblastoma: The LNESG1 Study of the European International Society of Pediatric Oncology Neuroblastoma GroupJournal of Clinical Oncology, 2005
- Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology GroupJournal of Clinical Oncology, 2005
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidThe New England Journal of Medicine, 1999
- Gain of Chromosome Arm 17q and Adverse Outcome in Patients with NeuroblastomaThe New England Journal of Medicine, 1999
- Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with NeuroblastomaThe New England Journal of Medicine, 1996
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993